Kim Seonil, Violette Caroline J, Ziff Edward B
Department of Biochemistry and Molecular Pharmacology, New York University Langone Medical Center, New York, NY, USA.
Bucknell University, PA, USA.
Neurobiol Aging. 2015 Dec;36(12):3239-3246. doi: 10.1016/j.neurobiolaging.2015.09.007. Epub 2015 Sep 18.
Alzheimer's disease (AD) is one of the most common neurodegenerative diseases characterized by memory loss and cognitive impairment. Whereas most AD cases are sporadic, some are caused by mutations in early-onset familial AD (FAD) genes. One FAD gene encodes presenilin 1 (PS1), and a PS1 mutation in methionine 146 impairs homeostatic synaptic plasticity (HSP). We have previously shown that Ca(2+) and calcineurin activity are critical regulators of HSP. Here, we confirm that endoplasmic reticulum-mediated Ca(2+) signals are increased in mutant PS1 neurons. We further show that calcineurin activity is abnormally elevated in the mutant and that inhibition of increased calcineurin activity stabilizes GluA1 phosphorylation, promoting synaptic trafficking of Ca(2+)-permeable α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors, contributing to the recovery of impaired HSP found in the mutant. Because HSP is suggested to have roles during learning and memory formation, increased calcineurin activity-induced impairment of HSP can cause cognitive decline in FAD. Thus, reducing abnormally increased calcineurin activity in AD brain may be beneficial for improving AD-related cognitive decline.
阿尔茨海默病(AD)是最常见的神经退行性疾病之一,其特征为记忆丧失和认知障碍。虽然大多数AD病例是散发性的,但有些是由早发性家族性AD(FAD)基因突变引起的。一个FAD基因编码早老素1(PS1),甲硫氨酸146处的PS1突变会损害稳态突触可塑性(HSP)。我们之前已经表明,Ca(2+)和钙调神经磷酸酶活性是HSP的关键调节因子。在此,我们证实内质网介导的Ca(2+)信号在突变型PS1神经元中增加。我们进一步表明,突变体中钙调神经磷酸酶活性异常升高,抑制钙调神经磷酸酶活性的增加可稳定GluA1磷酸化,促进Ca(2+)通透性α-氨基-3-羟基-5-甲基-4-异恶唑丙酸(AMPA)受体的突触转运,有助于恢复突变体中受损的HSP。由于HSP被认为在学习和记忆形成过程中起作用,钙调神经磷酸酶活性增加导致的HSP受损可导致FAD患者认知能力下降。因此,降低AD大脑中异常增加的钙调神经磷酸酶活性可能有助于改善与AD相关的认知能力下降。